FORA
Forian Inc. NASDAQ$2.15
Mkt Cap $67.1M
52w Low $1.64
47.7% of range
52w High $2.71
50d MA $2.10
200d MA $2.11
P/E (TTM)
-23.3x
EV/EBITDA
-23.7x
P/B
2.2x
Debt/Equity
0.0x
ROE
-9.7%
P/FCF
22.9x
RSI (14)
—
ATR (14)
—
Beta
0.99
50d MA
$2.10
200d MA
$2.11
Avg Volume
25.6K
About
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, deli…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | AMC | 0.01 | -0.04 | -500.0% | 2.06 | -1.0% | +0.5% | +0.5% | +1.0% | +1.9% | +4.4% | — |
| Nov 14, 2025 | AMC | 0.01 | 0.02 | +100.0% | 2.14 | -0.9% | +4.2% | -0.9% | -0.9% | -0.5% | +1.9% | — |
| Aug 13, 2025 | AMC | 0.01 | 0.03 | +200.0% | 1.90 | +1.6% | +1.6% | +5.3% | +3.2% | +0.0% | -0.5% | — |
| May 14, 2025 | AMC | 0.02 | -0.04 | -300.0% | 1.86 | +10.8% | +20.4% | +15.6% | +18.3% | +15.1% | +10.2% | — |
| Mar 31, 2025 | AMC | 0.02 | -0.01 | -150.0% | 2.00 | -5.0% | -2.0% | -4.5% | -5.0% | -4.0% | -4.0% | — |
| Nov 13, 2024 | AMC | 0.02 | 0.03 | +66.7% | 2.04 | -1.5% | -0.5% | -2.0% | -0.5% | +2.9% | +0.5% | — |
| Aug 14, 2024 | AMC | -0.01 | -0.03 | -300.0% | 2.47 | -5.7% | -2.8% | -2.4% | -1.6% | -2.8% | -2.8% | — |
| May 14, 2024 | AMC | — | 0.01 | — | 2.75 | +1.8% | +1.5% | -1.5% | -3.3% | -2.9% | -0.7% | — |
| Mar 28, 2024 | AMC | 0.01 | 0.04 | +233.3% | 3.32 | -1.2% | -13.9% | -13.0% | -7.8% | -8.4% | -11.7% | — |
| Nov 9, 2023 | AMC | 0.00 | 0.03 | +533.8% | 2.40 | +2.5% | +8.3% | +8.8% | +12.5% | +8.3% | +12.5% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14 | Roth MKM | Maintains | Buy → Buy | — | $2.04 | $2.01 | -1.5% | -0.5% | -2.0% | -0.5% | +2.9% | +0.5% |
| Apr 4 | Roth MKM | Maintains | Buy → Buy | — | $3.06 | $3.06 | +0.0% | -0.7% | -4.2% | -3.6% | -2.0% | -4.6% |
| Aug 11 | Lake Street | Maintains | Buy → Buy | — | $2.60 | $2.51 | -3.5% | -1.5% | -0.4% | +0.0% | -1.6% | -0.4% |
| Nov 10 | RBC Capital | Maintains | Outperform → Outperform | — | $3.30 | $3.41 | +3.3% | +1.8% | +4.5% | -3.0% | -8.5% | -12.7% |
| Apr 8 | Lake Street | Maintains | Buy → Buy | — | $5.43 | $5.56 | +2.4% | -5.5% | -6.8% | -11.2% | -13.4% | -16.0% |
Recent Filings
SC TO-T/A
! Medium
Forian Inc. -- Tender Offer Amendment
Forian Inc. amended its tender offer under Securities Exchange Act provisions, potentially affecting shareholder redemption options and deal terms.
May 4
SC TO-T
!!! Very High
Unknown — Tender Offer
FORA shareholders can sell shares at $2.17/share in a going-private transaction, representing the acquisition price investors should compare against current trading value to assess deal attractiveness.
Apr 16
SC TO-T
!!! Very High
Unknown — Tender Offer
A tender offer for FORA signals potential acquisition interest, which could trigger significant stock price movement upward if the offer price exceeds current trading levels, or downward if rejected or deemed undervalued.
Apr 16
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
FORA's merger closing is protected by a financing guarantee and capped expenses, reducing deal risk and signaling strong buyer commitment—investors should view this as increasing likelihood of successful completion.
Apr 3
8-K
Unknown — 8-K Filing
Forian reported 2025 full-year financial results, providing investors with comprehensive performance data to assess whether the company met expectations and validate its growth trajectory or signal concerning trends.
Mar 27
Data updated apr 25, 2026 9:44am
· Source: massive.com